Safety and Efficacy of Iguratimod in the Treatment of Chronic GVHD
NCT06244628
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
cGVHD
Interventions
DRUG:
Iguratimod
Sponsor
Xuzhou Medical University